Characteristics of long-COVID among older adults: a cross-sectional study
International Journal of Infectious Diseases, ISSN: 1201-9712, Vol: 125, Page: 287-293
2022
- 51Citations
- 91Captures
- 3Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations51
- Citation Indexes49
- 49
- CrossRef3
- Policy Citations2
- Policy Citation2
- Captures91
- Readers91
- 91
- Mentions3
- News Mentions3
- News3
Most Recent News
A social and medical examination of Long COVID as a “mass disabling event”: Part 3
The “mass disabling event” of the Long COVID disaster, for which the capitalist ruling elites internationally are implicated, amounts to one of the greatest social
Article Description
To describe long-COVID symptoms among older adults and to assess the risk factors for two common long-COVID symptoms: fatigue and dyspnea. This is a multicenter, prospective cohort study conducted in Israel, Switzerland, Spain, and Italy. Individuals were included at least 30 days after their COVID-19 diagnosis. We compared long-COVID symptoms between elderly (aged >65 years) and younger individuals (aged 18-65 years) and conducted univariate and multivariable analyses for the predictors of long-COVID fatigue and dyspnea. A total of 2333 individuals were evaluated at an average of 5 months (146 days [95% confidence interval 142-150]) after COVID-19 onset. The mean age was 51 years, and 20.5% were aged >65 years. Older adults were more likely to be symptomatic, with the most common symptoms being fatigue (38%) and dyspnea (30%); they were more likely to complain of cough and arthralgia and have abnormal chest imaging and pulmonary function tests. Independent risk factors for long-COVID fatigue and dyspnea included female gender, obesity, and closer proximity to COVID-19 diagnosis; older age was not an independent predictor. Older individuals with long-COVID have different persisting symptoms, with more pronounced pulmonary impairment. Women and individuals with obesity are at risk. Further research is warranted to investigate the natural history of long-COVID among the elderly population and to assess possible interventions aimed at promoting rehabilitation and well-being.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1201971222005355; http://dx.doi.org/10.1016/j.ijid.2022.09.035; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85144589410&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/36191820; https://linkinghub.elsevier.com/retrieve/pii/S1201971222005355; https://dx.doi.org/10.1016/j.ijid.2022.09.035
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know